181 related articles for article (PubMed ID: 38489678)
41. What is the quality of reporting in weight loss intervention studies? A systematic review of randomized controlled trials.
Thabane L; Chu R; Cuddy K; Douketis J
Int J Obes (Lond); 2007 Oct; 31(10):1554-9. PubMed ID: 17452988
[TBL] [Abstract][Full Text] [Related]
42. Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
Péron J; Pond GR; Gan HK; Chen EX; Almufti R; Maillet D; You B
J Natl Cancer Inst; 2012 Jul; 104(13):982-9. PubMed ID: 22761273
[TBL] [Abstract][Full Text] [Related]
43. Quality of reporting of randomised controlled trials in chiropractic using the CONSORT checklist.
Karpouzis F; Bonello R; Pribicevic M; Kalamir A; Brown BT
Chiropr Man Therap; 2016; 24():19. PubMed ID: 27284400
[TBL] [Abstract][Full Text] [Related]
44. Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals.
Kober T; Trelle S; Engert A
J Natl Cancer Inst; 2006 May; 98(9):620-5. PubMed ID: 16670387
[TBL] [Abstract][Full Text] [Related]
45. The Deficits of the Methodological and Reporting Quality of Randomized Controlled Trials in the Field of Prosthetics and Orthotics in Iran: A Systematic Review.
Shahabi S; Kiekens C; Mojgani P; Arienti C; ShahAli S; Lankarani KB
Rev Recent Clin Trials; 2023; 18(2):92-111. PubMed ID: 36809948
[TBL] [Abstract][Full Text] [Related]
46. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.
Strech D; Soltmann B; Weikert B; Bauer M; Pfennig A
J Clin Psychiatry; 2011 Sep; 72(9):1214-21. PubMed ID: 21294992
[TBL] [Abstract][Full Text] [Related]
47. Reporting quality of randomized controlled trials evaluating non-vitamin K oral anticoagulants in atrial fibrillation: a systematic review.
Yang Y; Han Y; Zou G; Sui Y; Jin J; Liu L
BMC Cardiovasc Disord; 2023 May; 23(1):229. PubMed ID: 37138211
[TBL] [Abstract][Full Text] [Related]
48. Methodologic Quality and Statistical Reporting of Physical Therapy Randomized Controlled Trials Relevant to Musculoskeletal Conditions.
Gonzalez GZ; Moseley AM; Maher CG; Nascimento DP; Costa LDCM; Costa LO
Arch Phys Med Rehabil; 2018 Jan; 99(1):129-136. PubMed ID: 28962828
[TBL] [Abstract][Full Text] [Related]
49. Quality of reporting of randomized controlled trials of herbal medicines conducted in metabolic disorders in Middle East countries: A systematic review.
Tabatabaei-Malazy O; Shadman Z; Ejtahed HS; Atlasi R; Abdollahi M; Larijani B
Complement Ther Med; 2018 Jun; 38():61-66. PubMed ID: 29857881
[TBL] [Abstract][Full Text] [Related]
50. The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China.
Wang G; Mao B; Xiong ZY; Fan T; Chen XD; Wang L; Liu GJ; Liu J; Guo J; Chang J; Wu TX; Li TQ;
Clin Ther; 2007 Jul; 29(7):1456-67. PubMed ID: 17825697
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement.
Yin Y; Shi F; Zhang Y; Zhang X; Ye J; Zhang J
PLoS One; 2021; 16(9):e0257093. PubMed ID: 34555033
[TBL] [Abstract][Full Text] [Related]
52. [Methodological quality and reporting quality evaluation of randomized controlled trials published in China Journal of Chinese Materia Medica].
Yu DD; Xie YM; Liao X; Zhi YJ; Jiang JJ; Chen W
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(4):833-839. PubMed ID: 29600662
[TBL] [Abstract][Full Text] [Related]
53. Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement.
Rikos D; Dardiotis E; Tsivgoulis G; Zintzaras E; Hadjigeorgiou GM
Mult Scler Relat Disord; 2016 Sep; 9():135-9. PubMed ID: 27645361
[TBL] [Abstract][Full Text] [Related]
54. Methodological reporting of randomized clinical trials in respiratory research in 2010.
Lu Y; Yao Q; Gu J; Shen C
Respir Care; 2013 Sep; 58(9):1546-51. PubMed ID: 23307824
[TBL] [Abstract][Full Text] [Related]
55. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies.
Fung AE; Palanki R; Bakri SJ; Depperschmidt E; Gibson A
Ophthalmology; 2009 Feb; 116(2):286-96. PubMed ID: 19091408
[TBL] [Abstract][Full Text] [Related]
56. Assessment of reporting quality of randomized controlled trials investigating the effects of inulin-type fructans supplementation on cardiovascular disease risk factors: A systematic survey.
Talukdar JR; Chu A; Garg A; Chowdhury F; E Harnack H; Huang L; Sikorski C; Mbuagbaw L; de Souza RJ
PLoS One; 2024; 19(1):e0292184. PubMed ID: 38166017
[TBL] [Abstract][Full Text] [Related]
57. Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.
Garnier L; Charton E; Falcoz A; Paget-Bailly S; Vernerey D; Jary M; Ducray F; Curtit E
Neurooncol Pract; 2021 Apr; 8(2):148-159. PubMed ID: 33898048
[TBL] [Abstract][Full Text] [Related]
58. Randomized controlled trials in adult traumatic brain injury: a review of compliance to CONSORT statement.
Lu J; Gary KW; Copolillo A; Ward J; Niemeier JP; Lapane KL
Arch Phys Med Rehabil; 2015 Apr; 96(4):702-14. PubMed ID: 25497515
[TBL] [Abstract][Full Text] [Related]
59. Sodium glucose co-transporter 2 inhibitors for glycemic control in type 2 diabetes mellitus: Quality of reporting of randomized controlled trials.
Mittal N; Mittal R; Kumar H; Medhi B
Perspect Clin Res; 2016; 7(1):21-7. PubMed ID: 26955572
[TBL] [Abstract][Full Text] [Related]
60. Reporting Quality of Randomized Controlled Trials in Restless Legs Syndrome Based on the CONSORT Statement.
Rikos D; Dardiotis E; Aloizou AM; Siokas V; Zintzaras E; Hadjigeorgiou GM
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]